Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trialChuanjie Wu, Lijun Wang, Yajun Lian et al.|Cephalalgia|2012Cited by 217
Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trialHaifeng Zhang, Chuanjie Wu, Yajun Lian et al.|The Journal of Headache and Pain|2014Cited by 170
Inhibition of the mitochondrial calcium uniporter inhibits Aβ-induced apoptosis by reducing reactive oxygen species-mediated endoplasmic reticulum stress in cultured microgliaNanchang Xie, Yajun Lian, Cui Wang et al.|Brain Research|2017Cited by 45
Botulinum toxin A in the treatment of trigeminal neuralgiaJian-Hua Xia, Yunqing Ma, Caihong He et al.|International Journal of Neuroscience|2015Cited by 42
The Potential Protective Effect of Curcumin on Amyloid-<i>β</i>-42 Induced Cytotoxicity in HT-22 CellsLu Zhang, Hongliang Xu, Yu Fang et al.|BioMed Research International|2018Cited by 34